In the last few months we've had many exciting developments at Felix! Check out the thread below to learn more about #Phage #ClinicalTrials, to take a look at our research & #scicomm efforts, and to meet new members of the Felix Team. (1/6)
First up, in January we announced "CYPHY," a Phase 1/2 investigator-initiated single center trial @Yale for targeted #phagetherapy using our lead asset, YPT-01, in the treatment of chronic P. aeruginosa infections in #cysticfibrosis.
https://www.prnewswire.com/news-releases/felix-biotechnology-announces-initiation-of-the-cyphy-phase-12-study-at-yale-for-its-lead-asset-targeting-p-aeruginosa-infections-301203098.html (2/6)
And last, but far from least, we've expanded our team! You can learn a little more about our new Head of Science, @Dr_Quest12 below and we'll introduce you to more members of the team in the weeks ahead. #Biotechnology #Career #Biotech (6/6)
You can follow @felixbiotech.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.